Microbiological Characteristics and Intestinal Probiotic Effects of Saccharomyces boulardii

被引：0
|
作者：
Xu X. [1 ]
Liang Z. [1 ]
机构：
[1] College of Food Science and Nutritional Engineering, China Agricultural University, Beijing
来源：
Journal of Chinese Institute of Food Science and Technology | 2024年 / 24卷 / 04期
关键词：
intestinal tract; probiotic effects; probiotics; Saccharomyces boulardii; taxonomic;
D O I：
10.16429/j.1009-7848.2024.04.042
中图分类号：
学科分类号：
摘要：
Saccharomyces boulardii (S. boulardii), a subspecies of S. cerevisiae, has a positive impact on intestinal homeostasis in humans and animals as a probiotic that can treat gastrointestinal diseases. S. boulardii has its own pheno-typic characteristics and physiological properties. However, it is genetically close to the model yeast S. cerevisiae, and it has been discussed for a long time as an independent species or divided into S. cerevisiae variants. Therefore, this paper first reviews the main genetic differences between S. boulardii and S. cerevisiae. Secondly, its ability to adapt to host physiological conditions is summarized, clarify its unique biological activities, including the optimal growth temperature and the ability to survive in the acidic environment of the gastrointestinal tract, which are the basis of its success as a probiotic. In addition, elucidating their intestinal probiotic effects in terms of various biological functions such as antitoxin properties, competitive rejection of pathogens, regulation of intestinal microbiome, stimulation of the intestinal mucosal immune system and trophic effects. Finally, the application status and prospects of S. boulardii in feed and food were summarized. S. boulardii has great potential as a novel probiotic preparation for human health and companion animal industries. © 2024 Chinese Institute of Food Science and Technology. All rights reserved.
引用
收藏
页码：444 / 455
页数：11
相关论文
共 96 条
  • [1] HILL С, GUARNER F, REID G, Et al., The international scientific association for probiotics and pre-biotics consensus statement on the scope and appropriate use of the term probiotic, Nat Rev Gastro Hepat, 11, 8, pp. 506-514, (2014)
  • [2] ZHANG W T, GUO L, LI J, Et al., Advances in relationship between probiotics and host diseases, Journal of Microbiology, 40, 4, pp. 90-97, (2020)
  • [3] MU Z Y, YANG Y J, WANG G Q, Et al., Beneficial effects of yeast and applications in food, Food Science, 42, 15, pp. 309-318, (2021)
  • [4] SEN S, MANSELL T J., Yeasts as probiotics: Mechanisms, outcomes, and future potential, Fungal Genet Biol, 137, (2020)
  • [5] ONO J, GREIG D, BOYNTON P J., Defining and disrupting species boundaries in Saccharomyces, Annu Rev Microbiol, 74, pp. 477-495, (2020)
  • [6] FU H B, LI J R, XU X H, Et al., Effectiveness and safety of Saccharomyces boulardii for the treatment of acute gastroenteritis in the pediatric population: A systematic review and meta-analysis of randomized controlled trials, Comput Math Method M, 10, (2022)
  • [7] MCFARLAND L V., Systematic review and meta -analysis of Saccharomyces boulardii in adult patients, World J Gastroentero, 16, 18, pp. 2202-2222, (2010)
  • [8] SAZAWAL S, HIREMATH G, DHINGRA U, Et al., Efficacy of probiotics in prevention of acute diarrhoea
  • [9] A meta -analysis of masked, randomised, placebo-controlled trials, Lancet Infect Dis, 6, 6, pp. 374-382, (2006)
  • [10] MCFARLAND L V., Common organisms and probiotics : Saccharomyces boulardii [M], Microbiota in Gastrointestinal Pathophysiology: Implications for Human Health, Prebiotics, Probiotics, and Dysbio-sis, pp. 145-164, (2017)
12345678910